×
About 14,338 results

ALLMedicine™ Alopecia Center

Research & Reviews  6,651 results

The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen...
https://doi.org/10.1111/pde.14543
Pediatric Dermatology; Imhof RL, Cantwell HM et. al.

Mar 1st, 2021 - There are few studies examining pediatric scarring alopecia. The objective of this study is to characterize the clinicopathologic findings, comorbidities, and treatment outcomes of pediatric patients with scarring alopecia. Retrospective review of...

JAAD Game Changers: Oral tofacitinib for the treatment of alopecia areata in children.
https://doi.org/10.1016/j.jaad.2021.02.014
Journal of the American Academy of Dermatology; Kamath S

Feb 28th, 2021 - JAAD Game Changers: Oral tofacitinib for the treatment of alopecia areata in children.|2021|Kamath S,|

Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients.
https://doi.org/10.1016/j.jaad.2021.02.054
Journal of the American Academy of Dermatology; Vano-Galvan S, Pirmez R et. al.

Feb 27th, 2021 - The major concern regarding the use of low-dose oral minoxidil (LDOM) in the treatment of hair loss is the potential risk of systemic adverse effects. To describe the safety of LDOM for the treatment of hair loss in a large cohort of patients. Ret...

Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with a...
https://doi.org/10.17219/acem/132069
Advances in Clinical and Experimental Medicine : Official... Czarnecka A, Odziomek A et. al.

Feb 26th, 2021 - Alopecia areata (AA) is the second most common cause of non-scarring alopecia. Little is known on the etiopathogenesis of AA. It is considered an autoimmune disease, with T lymphocytes and antibodies directed against hair follicle structures. Topi...

see more →

Guidelines  15 results

Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss...
https://doi.org/10.1111/1346-8138.14470
The Journal of Dermatology; Manabe M, Tsuboi R et. al.

Jun 4th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Guidelines for management of androgenetic alopecia based on BASP classification--the As...
https://doi.org/10.1111/jdv.12034
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.

Nov 27th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

British Association of Dermatologists' guidelines for the management of alopecia areata...
https://doi.org/10.1111/j.1365-2133.2012.10955.x
The British Journal of Dermatology; Messenger AG, McKillop J et. al.

Apr 24th, 2012 - British Association of Dermatologists' guidelines for the management of alopecia areata 2012.|2012|Messenger AG,McKillop J,Farrant P,McDonagh AJ,Sladden M,|diagnosis,etiology,therapy,methods,therapeutic use,methods,methods,methods,

Guidelines for the management of androgenetic alopecia (2010).
https://doi.org/10.1111/j.1346-8138.2011.01361.x
The Journal of Dermatology; Tsuboi R, Itami S et. al.

Dec 16th, 2011 - Guidelines for the management of androgenetic alopecia (2010).|2011|Tsuboi R,Itami S,Inui S,Ueki R,Katsuoka K,|therapeutic use,diagnosis,drug therapy,therapeutic use,transplantation,therapeutic use,therapeutic use,

S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adole...
https://doi.org/10.1111/j.1365-2133.2010.10011.x
The British Journal of Dermatology; Blume-Peytavi U, Blumeyer A et. al.

Aug 27th, 2010 - Androgenetic alopecia (AGA) is the most common hair loss disorder, affecting both men and women. Due to the frequency and the often significant impairment of life perceived by the affected patients, competent advice, diagnosis and treatment is par...

see more →

Drugs  89 results see all →

Clinicaltrials.gov  6,967 results

The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen...
https://doi.org/10.1111/pde.14543
Pediatric Dermatology; Imhof RL, Cantwell HM et. al.

Mar 1st, 2021 - There are few studies examining pediatric scarring alopecia. The objective of this study is to characterize the clinicopathologic findings, comorbidities, and treatment outcomes of pediatric patients with scarring alopecia. Retrospective review of...

JAAD Game Changers: Oral tofacitinib for the treatment of alopecia areata in children.
https://doi.org/10.1016/j.jaad.2021.02.014
Journal of the American Academy of Dermatology; Kamath S

Feb 28th, 2021 - JAAD Game Changers: Oral tofacitinib for the treatment of alopecia areata in children.|2021|Kamath S,|

Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients.
https://doi.org/10.1016/j.jaad.2021.02.054
Journal of the American Academy of Dermatology; Vano-Galvan S, Pirmez R et. al.

Feb 27th, 2021 - The major concern regarding the use of low-dose oral minoxidil (LDOM) in the treatment of hair loss is the potential risk of systemic adverse effects. To describe the safety of LDOM for the treatment of hair loss in a large cohort of patients. Ret...

Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with a...
https://doi.org/10.17219/acem/132069
Advances in Clinical and Experimental Medicine : Official... Czarnecka A, Odziomek A et. al.

Feb 26th, 2021 - Alopecia areata (AA) is the second most common cause of non-scarring alopecia. Little is known on the etiopathogenesis of AA. It is considered an autoimmune disease, with T lymphocytes and antibodies directed against hair follicle structures. Topi...

see more →

News  595 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Oral JAK Inhibitor for Alopecia Areata Advances to Phase 3
https://www.medscape.com/viewarticle/943625

Jan 5th, 2021 - An investigational oral selective Janus kinase 1 and JAK2 inhibitor maintained strong efficacy and tolerability for treatment of alopecia areata through 1 year of use in an ongoing open-label extension study of a trio of 24-week, phase 2 randomize...

New Treatment Options Show Promise for Centrifugal Cicatricial Alopecia
https://www.staging.medscape.com/viewarticle/938538

Oct 4th, 2020 - For patients with central centrifugal cicatricial alopecia (CCCA), several therapies showing benefit in case studies might reasonably be considered for those who have failed standard interventions, according to a review of current strategies for t...

New Treatment Options Show Promise for Centrifugal Cicatricial Alopecia
https://www.medscape.com/viewarticle/938538

Oct 4th, 2020 - For patients with central centrifugal cicatricial alopecia (CCCA), several therapies showing benefit in case studies might reasonably be considered for those who have failed standard interventions, according to a review of current strategies for t...

Consider Trichoscopy for Suspected Hair Disorders
https://www.medscape.com/viewarticle/935321

Aug 6th, 2020 - In the clinical experience of Bianca Maria Piraccini, MD, dermoscopic imaging of the scalp and hair can help physicians diagnose a variety of disorders that would normally require an invasive biopsy. Dermoscopic imaging, also known as trichoscopy,...

see more →

Patient Education  21 results see all →